Rabeprol 20 mg (Tablet (Enteric Coated))
Unit Price: ৳ 5.75 (6 x 10: ৳ 345.00)
Strip Price: ৳ 57.50
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Somatec pharmaceuticals ltd |
Also available as |
Indications
- Treatment of active duodenal ulcer
- Treatment of active benign gastric ulcer
- Symptomatic treatment of erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Long-term management of gastro-esophageal reflux disease (GERD)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Treatment of Zollinger-Ellison Syndrome
- Eradication of Helicobacter pylori in patients with peptic ulcer disease
Pharmacology
- Suppresses gastric acid secretion
- Inhibits the gastric H+/K+-ATPase
- Characterized as a gastric proton-pump inhibitor
Dosage
- Recommended oral dose for active duodenal ulcer and active benign gastric ulcer is 20 mg once daily in the morning
- Recommended oral dose for erosive or ulcerative gastro-esophageal reflux disease is 20 mg once daily for four to eight weeks
- Maintenance dose of rabeprazole sodium 20 mg or 10 mg once daily for long-term management
- Initial adult starting dose for Zollinger-Ellison Syndrome is 60 mg once a day, with possible titration upwards to 120 mg/day based on individual patient needs
- Recommended combination for eradication of Helicobacter pylori: Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily for 7 days
Administration
- Rabeprazole tablets should be taken in the morning before eating
- Tablets should not be chewed or crushed, but swallowed whole
Interaction
- Potential interaction with compounds whose absorption is pH dependent
- Co-administration with ketoconazole or itraconazole may decrease antifungal plasma levels
- No interaction observed with liquid antacids
- PPIs including rabeprazole should not be co-administered with atazanavir
Contraindications
- Hypersensitivity to the active substance or excipients
- Contra-indicated in pregnancy and during breastfeeding
Side Effects
- May cause headache, diarrhea, abdominal pain, vomiting, constipation, dry mouth, increased or decreased appetite, muscle pain, drowsiness, and dizziness
Pregnancy & Lactation
- US FDA pregnancy category 'C'
- No adequate and well-controlled studies in pregnant women
- Likely excretion in human milk
Precautions & Warnings
- Symptomatic response to therapy with Rabeprol does not exclude the presence of gastric or esophageal malignancy
- Patients on long-term treatment should be kept under regular surveillance
- Proton pump inhibitors may modestly increase the risk of hip, wrist, and spine fracture
- Risk of cross-hypersensitivity reactions with other proton pump inhibitors or substituted benzimidazoles
- Rabeprazole may reduce the absorption of vitamin B12
- May increase the risk of gastrointestinal infections such as Salmonella and Clostridium difficile
- Risk of hypomagnesaemia, hepatic enzyme abnormalities, and interference with laboratory tests
Use in Special Populations
- No dosage adjustment necessary for patients with renal or hepatic impairment
- Not recommended for use in children due to lack of data on safety and efficacy
Overdose Effects
- Maximum established exposure has not exceeded 60 mg twice daily or 160 mg once daily
- Effects are generally minimal, representative of known adverse event profile, and reversible without further medical intervention
- No specific antidote is known
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep below 30°C temperature, away from light and moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C18H21N3O3S
Common Questions about Rabeprol 20 mg Tablet
- Is a proton pump inhibitor (PPI) that suppresses gastric acid secretion
- Used to treat duodenal ulcer, gastric ulcer, GERD, Zollinger-Ellison Syndrome, and Helicobacter pylori eradication
- Common side effects include diarrhea, constipation, nausea, vomiting, headache, dizziness, rash, and dry mouth
- Should be taken with food, with the usual dose being one tablet once a day
- Not recommended for use during pregnancy or breastfeeding
- Overdose can cause symptoms such as drowsiness, confusion, and seizures
Related Brands
- Rabesec 20 mg (Tablet (Enteric Coated)) - drug-international-ltd
- Rabetac 20 mg (Tablet (Enteric Coated)) - navana-pharmaceuticals-ltd
- Rabifast 20 mg (Tablet (Enteric Coated)) - eskayef-pharmaceuticals-ltd
- Rabigut 20 mg (Tablet (Enteric Coated)) - popular-pharmaceuticals-ltd
- Rabium 20 mg (Tablet (Enteric Coated)) - cosmic-pharma-ltd